Dose-related antibody responses to purified Vero cell rabies vaccine in healthy Thai children

被引:0
|
作者
Chanthavanich, P [1 ]
Sabchareon, A [1 ]
Singhasivanon, V [1 ]
Pojjaroen-Anant, C [1 ]
Chongsuphajaisiddhi, T [1 ]
Kittikoon, P [1 ]
机构
[1] Mahidol Univ, Fac Trop Med, Dept Trop Pediat, Bangkok 10400, Thailand
来源
关键词
PVRV; dose-related; children;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To study whether the response to tissue culture rabies vaccine in children is dose related, 82 children aged 7-13 years (mean: 9.5 years), weighing 17-40 kg (mean: 25 kg), were divided randomly into three groups. All of the children received purified Vero cell rabies vaccine 2-1-1 intramuscular regimen (two sites on day 0, one site each on days 7 and 21). Group I (n = 29) received a full dose of 0.5 mt (antigenic value: 7.1 international units [IU]/dose), group II (n = 26) received a half dose of 0.25 mL (antigenic value: 3.55 IU/dose), and group III (n = 27) received a one-third dose of 0.15 mL (antigenic value: 2.13 IU/dose). The rapid fluorescent focus inhibition test (RFFIT) was used to measure the neutralizing antibody (Nab). The results showed that all of the children seroconverted (> 0.5 IU/mL) on day 14. The Nab responses were dose related. The geometric mean titers (GMT) on days 14, 28, 91, and 182 of group I were 23 (range: 4-134), 18 (range: 3-86), 3 (range: 1-25), and 1 (range. < 0.5-18) IU/mL, respectively. The GMT values of group II on the corresponding days were 20 (range: 5-186), 11 (range: 3-159), 1 (range: 0.5-14), and 1 (range: < 0.5-9) IU/mL. Although the Nab levels in group II were lower than those in group I, the differences were not statistically significant. The GMT of group III on days 14 and 28, which were 6 (range: 0.5-29) and 7 (range: 1-29) IU/mL, were significantly lower than those of groups I and II (P < 0.05). However, the GMT on days 91 and 182 of group III, 1 (range: < 0.5-10) and 0.5 (range: < 0.5-7) IU/mL, were not significantly different from those of groups I and II. In conclusion, when antigenic value of rabies vaccine is less than 2.5 IU/dose (group III), the immune response is relatively poor. The doses of rabies post-exposure vaccination in children should not be reduced.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 50 条
  • [1] Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML
    Madhusudana, Shampur N.
    Sanjay, Thitamaranahalli V.
    Mahendra, Bangalore J.
    Sudarshan, Mysore K.
    Narayana, Doddabele H. Ashwath
    Giri, Anand
    Muhamuda, Kader
    Ravi, Vasanthapuram
    Vakil, Hoshang B.
    Malerczyk, Cladius
    HUMAN VACCINES, 2006, 2 (05): : 200 - 204
  • [2] Persistence of antibodies in children after pre-exposure primary and booster immunizations with purified Vero cell rabies vaccine, chromatographically purified Vero cell rabies vaccine and human diploid cell vaccine
    Sabchareon, A
    RABIES CONTROL IN ASIA, 2001, : 29 - 41
  • [3] PURIFIED VERO CELL RABIES VACCINE AND HUMAN-DIPLOID CELL STRAIN VACCINE - COMPARISON OF NEUTRALIZING ANTIBODY-RESPONSES TO POSTEXPOSURE REGIMENS
    SUNTHARASAMAI, P
    CHANTHAVANICH, P
    WARRELL, MJ
    LOOAREESUWAN, S
    KARBWANG, J
    SUPANARANOND, W
    PHILLIPS, RE
    JANSAWAN, W
    XUEREF, C
    POURADIERDUTEIL, X
    WARRELL, DA
    JOURNAL OF HYGIENE, 1986, 96 (03) : 483 - 489
  • [4] Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
    Briggs, DJ
    Banzhoff, A
    Nicolay, U
    Sirikwin, S
    Dumavibhat, B
    Tongswas, S
    Wasi, C
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2000, 78 (05) : 693 - 698
  • [5] ONE YEAR BOOSTER VACCINATION WITH PURIFIED VERO CELL RABIES VACCINE
    SUNTHARASAMAI, P
    CHANTHAVANICH, P
    SUPANARANOND, W
    WARRELL, MJ
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1988, 82 (04) : 633 - 633
  • [6] Combined immunogenicity of purified Vero cell rabies vaccine and purified heat-treated equine rabies immunoglobulin
    Quiambao, BP
    Lang, J
    Miranda, MEG
    Mendez, B
    RABIES CONTROL IN ASIA, 1997, : 115 - 119
  • [7] HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES TO VARIOUS ECONOMICAL REGIMENS OF PURIFIED VERO CELL RABIES VACCINE
    PHANUPHAK, P
    KHAWPLOD, P
    SIRIVICHAYAKUL, S
    SIRIPRASOMSUB, W
    UBOL, S
    THAWEEPATHOMWAT, M
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1987, 5 (01): : 33 - 37
  • [8] Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)
    Lang, J
    Cetre, JC
    Picot, N
    Lanta, M
    Briantais, P
    Vital, S
    Le Mener, V
    Lutsch, C
    Rotivel, Y
    BIOLOGICALS, 1998, 26 (04) : 299 - 308
  • [9] A Comparative Study on the Adverse Reactions of Purified Chick Embryo Cell Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV)
    Ramezankhani, Roghieh
    Shirzadi, Mohammad Reza
    Ramezankhani, Azra
    Mozafary, Jamshid Poor
    ARCHIVES OF IRANIAN MEDICINE, 2016, 19 (07) : 502 - 507
  • [10] A new vero cell rabies vaccine: Results of a comparative trial with human diploid cell rabies vaccine in children
    Sabchareon, A
    Lang, J
    Attanath, P
    Sirivichayakul, C
    Pengsaa, K
    Le Mener, V
    Chantavanich, P
    Prarinyanuphab, V
    Pojjaroen-Anant, C
    Nimnual, S
    Wood, SC
    Riffard, P
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 141 - 149